orciprenaline (Compound)

Description: A compound in the knowledge graph

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View orciprenaline's neighborhood in the knowledge graph.

Submit

Knowledge Graph Assertions

Source	Relation	Target	Evidence
orciprenaline Compound (Entity type)	Negatively regulates Knowledge Graph Relation (Entity type)	CXCL14 Gene (Entity type)	-0.004958058
orciprenaline Compound (Entity type)	Negatively regulates Knowledge Graph Relation (Entity type)	ASS1 Gene (Entity type)	-0.0064674565
orciprenaline Compound (Entity type)	Negatively regulates Knowledge Graph Relation (Entity type)	MET Gene (Entity type)	-0.004474788
orciprenaline Compound (Entity type)	Negatively regulates Knowledge Graph Relation (Entity type)	CDC42EP3 Gene (Entity type)	-0.005310033
orciprenaline Compound (Entity type)	In similarity relationship with Knowledge Graph Relation (Entity type)	Ro 40-6055 Compound (Entity type)	0.5515578389167786
orciprenaline Compound (Entity type)	Negatively regulates Knowledge Graph Relation (Entity type)	LDOC1 Gene (Entity type)	-0.004420289
2-(4-(1-(quinolin-6-ylmethyl)-1H-[1,2,3]triazolo[4,5-b]pyrazin-6-yl)-1H-pyrazol-1-yl)ethanol Compound (Entity type)	In similarity relationship with Knowledge Graph Relation (Entity type)	orciprenaline Compound (Entity type)	0.4274737536907196
orciprenaline Compound (Entity type)	Negatively regulates Knowledge Graph Relation (Entity type)	DNAJA3 Gene (Entity type)	-0.004470394
orciprenaline Compound (Entity type)	Positively regulates Knowledge Graph Relation (Entity type)	S100A9 Gene (Entity type)	0.0047437856
(S)-1-[(S)-2-Hydroxy-4-((R)-(R)-2-hydroxy-indan-1-ylcarbamoyl)-5-(S)-phenyl-pentyl]-4-pyridin-3-ylmethyl-piperazine-2-carboxylic acid tert-butylamide Compound (Entity type)	In similarity relationship with Knowledge Graph Relation (Entity type)	orciprenaline Compound (Entity type)	0.4512761235237121

orciprenaline
Compound (Entity type)
Negatively regulates
Knowledge Graph Relation (Entity type)
CXCL14
Gene (Entity type)
-0.004958058

orciprenaline
Compound (Entity type)
Negatively regulates
Knowledge Graph Relation (Entity type)
ASS1
Gene (Entity type)
-0.0064674565

orciprenaline
Compound (Entity type)
Negatively regulates
Knowledge Graph Relation (Entity type)
MET
Gene (Entity type)
-0.004474788

orciprenaline
Compound (Entity type)
Negatively regulates
Knowledge Graph Relation (Entity type)
CDC42EP3
Gene (Entity type)
-0.005310033

orciprenaline
Compound (Entity type)
In similarity relationship with
Knowledge Graph Relation (Entity type)
Ro 40-6055
Compound (Entity type)
0.5515578389167786

orciprenaline
Compound (Entity type)
Negatively regulates
Knowledge Graph Relation (Entity type)
LDOC1
Gene (Entity type)
-0.004420289

2-(4-(1-(quinolin-6-ylmethyl)-1H-[1,2,3]triazolo[4,5-b]pyrazin-6-yl)-1H-pyrazol-1-yl)ethanol
Compound (Entity type)
In similarity relationship with
Knowledge Graph Relation (Entity type)
orciprenaline
Compound (Entity type)
0.4274737536907196

orciprenaline
Compound (Entity type)
Negatively regulates
Knowledge Graph Relation (Entity type)
DNAJA3
Gene (Entity type)
-0.004470394

orciprenaline
Compound (Entity type)
Positively regulates
Knowledge Graph Relation (Entity type)
S100A9
Gene (Entity type)
0.0047437856

(S)-1-[(S)-2-Hydroxy-4-((R)-(R)-2-hydroxy-indan-1-ylcarbamoyl)-5-(S)-phenyl-pentyl]-4-pyridin-3-ylmethyl-piperazine-2-carboxylic acid tert-butylamide
Compound (Entity type)
In similarity relationship with
Knowledge Graph Relation (Entity type)
orciprenaline
Compound (Entity type)
0.4512761235237121

DISPLAY PER PAGE

Knowledge Graph Assertions

	Source	Relation	Target	Evidence
Loading results...

DISPLAY PER PAGE

CFDE Workbench

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.